Table 3.
Significance of communication and telemedicine in urology during the COVID-19 pandemic.
| Very negative (1) | Negative (2) | Neutral (3) | Positive (4) | Very positive (5) | p Value | |
|---|---|---|---|---|---|---|
| How do you rate the quality of information in Germany regarding COVID-19? | 6.6 (39) | 14.1 (83) | 20.4 (120) | 49.4 (291) | 9.5 (56) | |
| Far too little (1) | Too little (2) | Just right (3) | Too much (4) | Far too much (5) | ||
| How do you rate the quantity of information in Germany regarding COVID-19? | 1.0 (6) | 10.9 (64) | 36.2 (213) | 43.6 (257) | 8.3 (49) | |
| Very low (1) | Low (2) | Moderate (3) | High (4) | Very high (5) | ||
| How do you rate the relevance of telemedical care/consultation during the COVID-19 pandemic? | 3.3 (19) | 19.0 (109) | 30.2 (173) | 32.6 (187) | 14.8 (85) | |
| Hospital Ambulatory health care center/medical practice |
0.6 (2) 6.7 (17) |
11.3 (36) 28.6 (73) |
26.7 (85) 34.5 (88) |
40.6 (129) 22.7 (58) |
20.8 (66) 7.5 (19) |
<0.001 |
| Not at all (1) | Only for individual cases (2) | Daily routine (3) | ||||
| Is there a possibility to reduce patient contact through telemedical approaches (eg, telephone consultation, videotelephony) at your institution? | 29.1 (167) | 50.1 (287) | 20.8 (119) | |||
| Hospital Ambulatory health care center/medical practice |
38.0 (121) 18.0 (46) |
45.0 (143) 56.5 (144) |
17.0 (54) 25.5 (65) |
<0.001 | ||
| No (1) | Partly (2) | Yes (3) | ||||
| Are there any technical or regulatory restrictions regarding the use of telemedicine during the COVID-19 pandemic at your institution? | 35.1 (201) | 40.1 (230) | 24.8 (142) | |||
| Hospital Ambulatory health care center/medical practice |
30.8 (98) 40.4 (103) |
45.0 (143) 34.1 (87) |
24.2 (77) 25.5 (65) |
0.161 | ||
In case of multiple pairwise comparisons, the level of significance was adjusted by Bonferroni correction. For three groups (three pairwise comparisons), a p-value of p=0.017 was considered statistically significant.